A study to investigate the effect of Lepodisiran, a subcutaneous injection, with hopes to reduce the risk of major cardiovascular events (heart attacks, strokes, needing stents, bypass surgery) by decreasing lipoprotein a values.
Enrollment
Open
Patient Commitment Duration
4-5 years
Number of visits in study
24 (this includes an extended maintenance period)
Patient Compensation
Varies with each completed visit ranged from $28-$112
"*" indicates required fields
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
A 48-week, phase 3 study to investigate the efficacy and safety of Retatrutide compared with placebo in adult participants with type II diabetes and inadequate glycemic control with diet and exercise alone.
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
Elagolix in combination with combined oral contraceptives in women with moderate-to-severe endometriosis pain.
Enrollment
Open
Patient Commitment Duration
45 months
Number of visits in study
14 onsite visits, 10 telephone visits
Patient Compensation
$25-100 payment varies per visit
"*" indicates required fields
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
The purpose of this study is to compare the effects of an experimental drug, Milvexian, to the comparator drug, Apixaban (Eliquis) to determine if it is safe and useful in reducing the risk of stroke and blood clots outside the brain in participants with atrial fibrillation.
Enrollment
Open
Patient Commitment Duration
3.5-4 years
Number of visits in study
Up to 15 visits
Patient Compensation
$100 per visit
"*" indicates required fields
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
A clinical trial in healthy volunteers to study the safety, tolerability, and immune responses after vaccination with an investigational vaccine designed to prevent genital herpes lesions.
Enrollment
Open
Patient Commitment Duration
18 months
Number of visits in study
12 scheduled in person visits, 1 phone call
Patient Compensation
$205 for the 12 scheduled visits. $130 for phone call visit and any unscheduled visits.
"*" indicates required fields
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
Description: A research study is evaluating an investigational for COPD when added to standard-of-care treatment in adults needing additional therapy. This research study may be an option if you:
Have been diagnosed with COPD for more than 1 year
Have a history of at least 2 moderate exacerbations (having to use systemic corticosteroids and/or treatment with antibiotics) or 1 severe exacerbation (requiring hospitalization) within the last year
Have experienced symptoms of chronic bronchitis for at least 3 months in the past year (productive cough, shortness of breath, wheezing, chest tightness)
Are required to be on a standard therapy for COPD
Other criteria apply. Please make sure to discuss this study with a member of our research staff to ensure this research study is a good fit for you. Qualified participants will receive all study-related care and study medication (including standard of care treatment) at no cost.
Enrollment: Open
Patient Commitment Duration: Approximately 12 months
Number of visits in study: Approximately 15 visits
Patient Compensation: Financial compensation will be provided for time and travel expenses. Current background inhalers will also be provided.
"*" indicates required fields
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
A 12-month study providing FDA approved oral testosterone replacement therapy JATENZO in men diagnosed with hypogonadism to assess adrenal insufficiency.
Enrollment
Open
Patient Commitment Duration
12 months
Number of visits in study
13
Patient Compensation
$53 per visit
"*" indicates required fields
The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial. Please call 910-799-5500 between the hours of 8am-5pm for general research questions.
